Novolog (pharm-up 1966) Ltd NVLG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 19.42
- Price/Sales
- 0.45
- Dividend Yield (Trailing)
- 3.97%
- Dividend Yield (Forward)
- 3.97%
- Total Yield
- 3.97%
Company Profile
Novolog (pharm-up 1966) Ltd is an Israeli public health care company. The company operates in four divisions: The digital division, Health Division, The logistics division and International health services.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 955
- Website
- http://www.novolog.co.il
Comparables
Valuation
|
Metric
|
NVLG
|
GNRS
|
TRPZ
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.42 | 6.37 | 33.98 |
Price/Book Value | 1.99 | 0.38 | 4.08 |
Price/Sales | 0.45 | 8.36 | 2.99 |
Price/Cash Flow | 9.94 | 31.92 | 17.97 |
Price/Earnings
NVLG
GNRS
TRPZ
Financial Strength
|
Metric
|
NVLG
|
GNRS
|
TRPZ
|
|---|---|---|---|
Quick Ratio | 0.86 | 1.02 | 1.12 |
Current Ratio | 0.96 | 1.02 | 1.78 |
Interest Coverage | 0.16 | 3.32 | 8.01 |
Quick Ratio
NVLG
GNRS
TRPZ
Profitability
|
Metric
|
NVLG
|
GNRS
|
TRPZ
|
|---|---|---|---|
Return on Assets (Normalized) | 1.39% | 4.05% | 5.81% |
Return on Equity (Normalized) | 10.12% | 8.01% | 13.56% |
Return on Invested Capital (Normalized) | 6.61% | 6.19% | 10.35% |
Return on Assets
NVLG
GNRS
TRPZ
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| Pjbsgcgy | Dsgnqt | $62.1 Bil | |||
| Cencora Inc
COR
| Tzwvlxt | Xtyzsgm | $43.9 Bil | |||
| Cardinal Health Inc
CAH
| Xtwmhlhs | Pyfwqh | $26.4 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
| — | Pbtxwp | $9.2 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
| — | Ctsmy | $9.2 Bil | |||
| Sinopharm Group Co Ltd
SHTDF
| — | Cszcp | $7.5 Bil | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | Shwrq | $7.5 Bil | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | Fhvdyhf | $6.6 Bil | |||
| Ebos Group Ltd ADR
EBOSY
| — | Dwyss | $4.5 Bil | |||
| Medipal Holdings Corp ADR
MAHLY
| — | Wrqq | $3.7 Bil |
United States